相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interferon-γ impairs proliferation of hematopoietic stem cells in mice
Alexander M. de Bruin et al.
BLOOD (2013)
Critical requirement for Stat5 in a mouse model of polycythemia vera
Dongqing Yan et al.
BLOOD (2012)
Distinct roles for long-term hematopoietic stem cells and erythroid precursor cells in a murine model of Jak2V617F-mediated polycythemia vera
Ann Mullally et al.
BLOOD (2012)
JAK inhibitors for myeloproliferative neoplasms: clarifying facts from myths
Ayalew Tefferi
BLOOD (2012)
Dnmt3a is essential for hematopoietic stem cell differentiation
Grant A. Challen et al.
NATURE GENETICS (2012)
R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasm
Kotaro Shide et al.
BLOOD (2011)
Effects of the JAK2 mutation on the hematopoietic stem and progenitor compartment in human myeloproliferative neoplasms
Shubha Anand et al.
BLOOD (2011)
New mutations and pathogenesis of myeloproliferative neoplasms
William Vainchenker et al.
BLOOD (2011)
The renaissance of interferon therapy for the treatment of myeloid malignancies
Jean-Jacques Kiladjian et al.
BLOOD (2011)
TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis
Cyril Quivoron et al.
CANCER CELL (2011)
Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
Kelly Moran-Crusio et al.
CANCER CELL (2011)
Regulation of effector and memory T-cell functions by type I interferon
Jonathan P. Huber et al.
IMMUNOLOGY (2011)
Recent advances on the immunomodulatory effects of IFN-α: Implications for cancer immunotherapy and autoimmunity
Paola Rizza et al.
AUTOIMMUNITY (2010)
Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice
Caroline Marty et al.
BLOOD (2010)
Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease
Hajime Akada et al.
BLOOD (2010)
JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia
Juan Li et al.
BLOOD (2010)
Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells
Ann Mullally et al.
CANCER CELL (2010)
Clonal analysis of erythroid progenitors suggests that pegylated interferon α-2a treatment targets JAK2V617F clones without affecting TET2 mutant cells
J-J Kiladjian et al.
LEUKEMIA (2010)
IFNα activates dormant haematopoietic stem cells in vivo
Marieke A. G. Essers et al.
NATURE (2009)
Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion
Taku Sato et al.
NATURE MEDICINE (2009)
Mutation in TET2 in Myeloid Cancers
Francois Delhommeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity
Chloe James et al.
BLOOD (2008)
Interferon-α2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes
Akiko Yamane et al.
BLOOD (2008)
Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
Jean-Jacques Kiladjian et al.
BLOOD (2008)
Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
Ralph Tiedt et al.
BLOOD (2008)
Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells
Hong Qian et al.
CELL STEM CELL (2007)
Adopting the good reFLEXes when generating conditional alterations in the mouse genome
Frank Schnuetgen et al.
TRANSGENIC RESEARCH (2007)
The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera
Sabrina Dupont et al.
BLOOD (2007)
Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model
Gerlinde Wernig et al.
BLOOD (2006)
The GOD of hematopoietic stem cells - A clonal diversity model of the stem cell compartment
C. E. Muller-Sieburg et al.
CELL CYCLE (2006)
JAK2(V617F) expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis
Catherine Lacout et al.
BLOOD (2006)
The kinetics of clonal dominance in myeloproliferative disorders
SN Catlin et al.
BLOOD (2005)
SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells
MJ Kiel et al.
CELL (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
EJ Baxter et al.
LANCET (2005)
Regulatory elements of the vav gene drive transgene expression in hematopoietic stem cells from adult mice
E Almarza et al.
EXPERIMENTAL HEMATOLOGY (2004)
SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis
BA Croker et al.
IMMUNITY (2004)
Pivotal role of granulocyte colony-stimulating factor in the development of progenitors in the common myeloid pathway
MK Richards et al.
BLOOD (2003)
vavCre transgenic mice:: A tool for mutagenesis in hematopoietic and endothelial lineages
P Georgiades et al.
GENESIS (2002)
分享论文
